Rivus posts a win for its experimental weight problems drug in middle failure sufferers
Rivus Pharmaceuticals’ exin line withimalestal automobilediometabolic drug, HU6, nailed a mid-stage trial in overweight patients with middle failure, to finding that patients notched a statistically significant reduction in … Signal as much